首页> 外国专利> Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors

Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors

机译:转基因间充质干细胞稳定表达肿瘤坏死因子相关的凋亡诱导配体,例如对治疗肿瘤有用

摘要

Transgenic mesenchymal stem cells stably expressing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) are produced by retroviral transduction with TRAIL cDNA cloned into a retroviral transduction system with a self-inactivating 3' long terminal repeat. An independent claim is also included for producing cells as above by isolating mesenchymal stem cells from the mononuclear cell fraction of tissues, e.g. bone marrow, adipose tissue or cord vein blood, by plastic adherence, culturing the cells in an expansion medium and transducing the cells with tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) cDNA cloned into retroviral transduction system after reverse transcription and sequence-specific amplification. ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.
机译:稳定表达肿瘤坏死因子(TNF)相关凋亡诱导配体(TRAIL)的转基因间充质干细胞是通过将TRAIL cDNA克隆到具有自灭活3'长末端重复序列的逆转录病毒转导系统中而产生的。还包括通过从组织的单核细胞级分中分离间充质干细胞来产生上述细胞的独立权利要求。骨髓,脂肪组织或脐静脉血,通过塑性粘附,在扩增培养基中培养细胞,并通过反转录后将其与肿瘤坏死因子(TNF)相关的凋亡诱导配体(TRAIL)cDNA克隆到逆转录病毒转导系统中进行转导和序列特异性扩增。活动:细胞静息。作用机理:未给出。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号